GR.SARANTIS S.A. (“the Company”) announces that, in implementation of the resolution of the Shareholders’ Annual General Meeting dated May 31st 2022, the Company proceeded on January 29th 2024 with the purchase of 10,150 own shares at the average price of 8.
GR. SARANTIS S.A. (“the Company”) announces that, in implementation of the resolution of the Shareholders’ Annual General Meeting dated May 31st 2022, the Company proceeded on January 26th 2024 with the purchase of 3,000 own shares at the average price of 8.
GR. SARANTIS S.A. (“the Company”) announces that, in implementation of the resolution of the Shareholders’ Annual General Meeting dated May 31st 2022, the Company proceeded on January 25th 2024 with the purchase of 9,150 own shares at the average price of 8.
GR. SARANTIS S.A. (“the Company”) announces that, in implementation of the resolution of the Shareholders’ Annual General Meeting dated May 31st 2022, the Company proceeded on January 24th 2024 with the purchase of 9,600 own shares at the average price of 8.
GR. SARANTIS S.A. (“the Company”) announces that, in implementation of the resolution of the Shareholders’ Annual General Meeting dated May 31st 2022, the Company proceeded on January 23rd 2024 with the purchase of 5,755 own shares at the average price of 8.
The company GR. SARANTIS S.A. announces, according to the articles 3 and 21 of the L.3556/2007 and the provisions of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, that the company Lenidi S.
GR. SARANTIS S.A. (“the Company”) announces that, in implementation of the resolution of the Shareholders’ Annual General Meeting dated May 31st 2022, the Company proceeded on January 22nd 2024 with the purchase of 13,100 own shares at the average price of 8.
Sarantis Group recognized at the Annual Bravo National Dialogue for Sustainable Development for the initiative “Sarantis Group launches clinéa, the refillable clean pharmacy skincare brand” in the “MARKET” category.